A boring question about bioavailability? [Off Topic]
According to the guideline, "absolute bioavailabiliy" is defined as bioavailability of formulation A compared to formulation B (which is a intravenous formulation), while "relative bioavailability" is defined when formulation B is a non-intravenous formulation.
So here is the question, if two formulation are both intravenous formulation, should I call is absolute BA study or relative BA study?
Edit: Please follow the Forum’s Policy. [Helmut]
So here is the question, if two formulation are both intravenous formulation, should I call is absolute BA study or relative BA study?
Edit: Please follow the Forum’s Policy. [Helmut]
Complete thread:
- A boring question about bioavailability?Darborn 2024-08-01 09:05
- ƒ of IV = 1 by definition, but… Helmut 2024-08-01 12:05
- ƒ of IV = 1 by definition, but… Darborn 2024-08-01 12:36
- IV: Different half-lives? Helmut 2024-08-01 13:43
- IV: Different half-lives? Darborn 2024-08-02 02:39
- IV: Liposome encapsuled drug, pegylated biologic? Helmut 2024-08-02 07:52
- IV: Liposome encapsuled drug, pegylated biologic? Darborn 2024-08-06 05:15
- IV: Liposome encapsuled drug, pegylated biologic? Helmut 2024-08-02 07:52
- IV: Different half-lives? Darborn 2024-08-02 02:39
- IV: Different half-lives? Helmut 2024-08-01 13:43
- ƒ of IV = 1 by definition, but… Darborn 2024-08-01 12:36
- ƒ of IV = 1 by definition, but… Helmut 2024-08-01 12:05